Pharmaceuticals Ultrasector Profund Fund Manager Performance Evaluation
| PHPIX Fund | USD 36.38 0.35 0.97% |
The fund holds a Beta of 0.76, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharmaceuticals Ultrasector's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharmaceuticals Ultrasector is expected to be smaller as well.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in March 2026.
...more| Expense Ratio Date | 28th of November 2025 | |
| Expense Ratio | 1.7800 |
Pharmaceuticals |
Pharmaceuticals Ultrasector Relative Risk vs. Return Landscape
If you would invest 3,343 in Pharmaceuticals Ultrasector Profund on November 28, 2025 and sell it today you would earn a total of 295.00 from holding Pharmaceuticals Ultrasector Profund or generate 8.82% return on investment over 90 days. Pharmaceuticals Ultrasector Profund is currently producing 0.1587% returns and takes up 2.0186% volatility of returns over 90 trading days. Put another way, 18% of traded mutual funds are less volatile than Pharmaceuticals, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pharmaceuticals Ultrasector Current Valuation
Overvalued
Today
Please note that Pharmaceuticals Ultrasector's price fluctuation is very steady at this time. At this time, the fund appears to be overvalued. Pharmaceuticals Ultrasector holds a recent Real Value of $32.96 per share. The prevailing price of the fund is $36.38. We determine the value of Pharmaceuticals Ultrasector from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we support acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Since Pharmaceuticals Ultrasector is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmaceuticals Mutual Fund. However, Pharmaceuticals Ultrasector's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.38 | Real 32.96 | Hype 36.38 | Naive 36.12 |
The intrinsic value of Pharmaceuticals Ultrasector's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pharmaceuticals Ultrasector's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pharmaceuticals Ultrasector Profund helps investors to forecast how Pharmaceuticals mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmaceuticals Ultrasector more accurately as focusing exclusively on Pharmaceuticals Ultrasector's fundamentals will not take into account other important factors: Pharmaceuticals Ultrasector Target Price Odds to finish over Current Price
The tendency of Pharmaceuticals Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 36.38 | 90 days | 36.38 | about 5.66 |
Based on a normal probability distribution, the odds of Pharmaceuticals Ultrasector to move above the current price in 90 days from now is about 5.66 (This Pharmaceuticals Ultrasector Profund probability density function shows the probability of Pharmaceuticals Mutual Fund to fall within a particular range of prices over 90 days) .
Pharmaceuticals Ultrasector Price Density |
| Price |
Predictive Modules for Pharmaceuticals Ultrasector
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmaceuticals Ultrasector. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pharmaceuticals Ultrasector Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharmaceuticals Ultrasector is not an exception. The market had few large corrections towards the Pharmaceuticals Ultrasector's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharmaceuticals Ultrasector Profund, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharmaceuticals Ultrasector within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.17 | |
β | Beta against Dow Jones | 0.76 | |
σ | Overall volatility | 1.25 | |
Ir | Information ratio | 0.07 |
Pharmaceuticals Ultrasector Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmaceuticals Ultrasector for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmaceuticals Ultrasector can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The fund maintains about 19.93% of its assets in cash |
Pharmaceuticals Ultrasector Fundamentals Growth
Pharmaceuticals Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Pharmaceuticals Ultrasector, and Pharmaceuticals Ultrasector fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmaceuticals Mutual Fund performance.
| Price To Earning | 6.90 X | ||||
| Price To Book | 2.77 X | ||||
| Price To Sales | 4.71 X | ||||
| Total Asset | 3.61 M | ||||
About Pharmaceuticals Ultrasector Performance
Evaluating Pharmaceuticals Ultrasector's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Pharmaceuticals Ultrasector has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmaceuticals Ultrasector has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. The fund is non-diversified.Things to note about Pharmaceuticals Ultrasector performance evaluation
Checking the ongoing alerts about Pharmaceuticals Ultrasector for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Pharmaceuticals Ultrasector help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The fund maintains about 19.93% of its assets in cash |
- Analyzing Pharmaceuticals Ultrasector's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmaceuticals Ultrasector's stock is overvalued or undervalued compared to its peers.
- Examining Pharmaceuticals Ultrasector's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmaceuticals Ultrasector's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmaceuticals Ultrasector's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Pharmaceuticals Ultrasector's mutual fund. These opinions can provide insight into Pharmaceuticals Ultrasector's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |